Serum Contactin-1 in CIDP: A Cross-Sectional Study.

Luuk Wieske Lorena Martín-AguilarJanev FehmiCinta LleixàMarleen J A Koel-SimmelinkMadhurima ChatterjeeZoë van LieropJoep KillesteinCamiel VerhammeLuis Antonio Querol-Gutiérrez Simon Rinaldi Charlotte E TeunissenFilip Eftimov

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

This study provides class II evidence that serum contactin-1 levels can discriminate between patients with CIDP with or without paranodal antibodies with a sensitivity of 71% (95% CI: 56%-85%) and a specificity of 97% (95% CI: 83%-100%).

Keyphrases

physical activity
risk factors